東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Randomized Controlled Trial to Evalu...

Da Paz, Nikko Symonne.

Linked to FindBook

Google Book

Amazon

博客來

Randomized Controlled Trial to Evaluate Written Disclosure as Treatment for Parents of Children with Autism Spectrum Disorders.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Randomized Controlled Trial to Evaluate Written Disclosure as Treatment for Parents of Children with Autism Spectrum Disorders./
Author:	Da Paz, Nikko Symonne.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2016,
Description:	36 p.
Notes:	Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.
Contained By:	Dissertation Abstracts International77-10B(E).
Subject:	Developmental psychology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10129621
ISBN:	9781339875125

Randomized Controlled Trial to Evaluate Written Disclosure as Treatment for Parents of Children with Autism Spectrum Disorders.
Da Paz, Nikko Symonne.

Randomized Controlled Trial to Evaluate Written Disclosure as Treatment for Parents of Children with Autism Spectrum Disorders. - Ann Arbor : ProQuest Dissertations & Theses, 2016 - 36 p.

Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.

Thesis (Ph.D.)--University of California, Merced, 2016.

Parents of children with autism spectrum disorders experience poorer health and greater stress than parents in the general population. With prevalence rates of ASD rapidly increasing, it is imperative to identify effective interventions targeting parent health and well-being. Investigations of written disclosure (WD) have shown promising results in the general population but a paucity of research has evaluated WD with parents of children with ASD. Further, subjective reports have traditionally provided evidence for treatment efficacy. To address these limitations, we conducted a randomized controlled trial with 71 parents of children with ASD (ages 23 to 62 years; M = 38.0, SD = 10.35). At baseline and 6-month follow-up, we evaluated self-reported health (global health, perceived stress, parenting stress, and caregiver strain) and objective biomarkers (salivary cortisol and ambulatory blood pressure). We hypothesized that parents who wrote about traumatic events (treatment) would display better health compared to parents who wrote about a neutral topic (control). As expected, treatment parents displayed more robust cortisol activity, F(1,52) = 12.08; p = .002, and reported less perceived stress, F(1,56) = 9.14; p = .004. While conditions did not differ at follow-up, parenting stress (F(1,56) = 7.64; p = .008) and caregiver strain (F(1,56) = 6.46; p = .014) were reported significantly better for all parents over time. There were no differences between conditions in global health and blood pressure. Thus, results partially support WD as an effective treatment for parents of children with ASD. Given the small sample size, caution is warranted for generalizability.

ISBN: 9781339875125Subjects--Topical Terms:

516948
Developmental psychology.

Randomized Controlled Trial to Evaluate Written Disclosure as Treatment for Parents of Children with Autism Spectrum Disorders.
LDR:02681nmm a2200301 4500 001 2123954
005 20171023101701.5
008 180830s2016 ||||||||||||||||| ||eng d
020 $a 9781339875125
035 $a (MiAaPQ)AAI10129621
035 $a AAI10129621
040 $a MiAaPQ $c MiAaPQ
100 1 $a Da Paz, Nikko Symonne. $3 3285914
245 1 0 $a Randomized Controlled Trial to Evaluate Written Disclosure as Treatment for Parents of Children with Autism Spectrum Disorders.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2016
300 $a 36 p.
500 $a Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.
500 $a Adviser: Jan L. Wallander.
502 $a Thesis (Ph.D.)--University of California, Merced, 2016.
520 $a Parents of children with autism spectrum disorders experience poorer health and greater stress than parents in the general population. With prevalence rates of ASD rapidly increasing, it is imperative to identify effective interventions targeting parent health and well-being. Investigations of written disclosure (WD) have shown promising results in the general population but a paucity of research has evaluated WD with parents of children with ASD. Further, subjective reports have traditionally provided evidence for treatment efficacy. To address these limitations, we conducted a randomized controlled trial with 71 parents of children with ASD (ages 23 to 62 years; M = 38.0, SD = 10.35). At baseline and 6-month follow-up, we evaluated self-reported health (global health, perceived stress, parenting stress, and caregiver strain) and objective biomarkers (salivary cortisol and ambulatory blood pressure). We hypothesized that parents who wrote about traumatic events (treatment) would display better health compared to parents who wrote about a neutral topic (control). As expected, treatment parents displayed more robust cortisol activity, F(1,52) = 12.08; p = .002, and reported less perceived stress, F(1,56) = 9.14; p = .004. While conditions did not differ at follow-up, parenting stress (F(1,56) = 7.64; p = .008) and caregiver strain (F(1,56) = 6.46; p = .014) were reported significantly better for all parents over time. There were no differences between conditions in global health and blood pressure. Thus, results partially support WD as an effective treatment for parents of children with ASD. Given the small sample size, caution is warranted for generalizability.
590 $a School code: 1660.
650 4 $a Developmental psychology. $3 516948
650 4 $a Endocrinology. $3 610914
650 4 $a Psychobiology. $3 555678
690 $a 0620
690 $a 0409
690 $a 0349
710 2 $a University of California, Merced. $b Psychological Sciences. $3 3282194
773 0 $t Dissertation Abstracts International $g 77-10B(E).
790 $a 1660
791 $a Ph.D.
792 $a 2016
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10129621